The misuse of GLP-1 drugs without clinical oversight can lead to severe health complications. GLP-1 receptor agonist drugs carry serious side effects ranging from nausea and vomiting to pancreatitis, acute kidney injury, bowel obstruction, and medullary thyroid cancer, the Ministry of Health and Family Welfare warned on 1 April, 2026
In certain cases, providers may consider combination protocols
Tracking is available via email and the patient portal
Use non-oral method or add barrier method for 4 weeks after each change
We recommend that you consult with a qualified healthcare provider prior to making any medical decisions or changing any medications or dosages
These studies suggest that despite the potential benefits of Lira, current evidence does not advocate the use of Lira in patients with NAFLD